These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 70687)
21. Human T-lymphocyte differentiation in immunodeficiency diseases and after reconstitution by bone marrow or fetal thymus transplantation. Touraine JL Clin Immunol Immunopathol; 1979 Feb; 12(2):228-37. PubMed ID: 369754 [No Abstract] [Full Text] [Related]
22. Evidence that appearance of thymulin in plasma follows lymphoid chimerism and precedes development of immunity in patients with lethal combined immunodeficiency transplanted with T cell-depleted haploidentical marrow. Incefy GS; Flomenberg N; Heller G; Kernan NA; Brochstein J; Kirkpatrick D; Kapoor N; Groshen S; O'Reilly RJ Transplantation; 1990 Jul; 50(1):55-61. PubMed ID: 2368151 [TBL] [Abstract][Full Text] [Related]
24. Bioassay determinations of thymopoietin and thymic hormone levels in human plasma. Twomey JJ; Goldstein G; Lewis VM; Bealmear PM; Good RA Proc Natl Acad Sci U S A; 1977 Jun; 74(6):2541-5. PubMed ID: 302007 [TBL] [Abstract][Full Text] [Related]
25. Zinc deficiency, depressed thymic hormones, and T lymphocyte dysfunction in patients with hypogammaglobulinemia. Cunningham-Rundles C; Cunningham-Rundles S; Iwata T; Incefy G; Garofalo JA; Menendez-Botet C; Lewis V; Twomey JJ; Good RA Clin Immunol Immunopathol; 1981 Dec; 21(3):387-96. PubMed ID: 6976865 [No Abstract] [Full Text] [Related]
26. The thymus in immunodeficiency diseases: new therapeutic approaches. Bach JF Birth Defects Orig Artic Ser; 1983; 19(3):245-53. PubMed ID: 6360235 [No Abstract] [Full Text] [Related]
28. Bone marrow transplantation and thymopoietin pentapeptide treatment in two infants with immunodeficiency with predominant T-cell defects. Businco L; Rossi P; Paganelli R; Galli E; DiGilio G; Lulli P; Aiuti F Clin Immunol Immunopathol; 1984 Oct; 33(1):123-30. PubMed ID: 6383671 [TBL] [Abstract][Full Text] [Related]
29. Immunologic reconstitution with bone marrow transplantation and thymic hormones in two patients with severe pure T-cell defects. Businco L; Rossi P; Paganelli R; Seminara R; Aiuti F Birth Defects Orig Artic Ser; 1983; 19(3):281-5. PubMed ID: 6360241 [No Abstract] [Full Text] [Related]
30. [Thymus and immunodeficiency disease--with special reference to transplantation of fetal thymus and cultured thymic epithelium]. Matsumoto S; Sakiyama Y; Tsuneta H; Takahashi Y Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Jan; 23(1):38-44. PubMed ID: 3892114 [No Abstract] [Full Text] [Related]
31. Workshop on severe combined immunological deficiency disease and adenosine deaminase deficiency. Albany, New York, on October 1, 1973. Pickering RJ; Pollara B; Meuwissen HJ Clin Immunol Immunopathol; 1974 Nov; 3(2):301-3. PubMed ID: 4615852 [No Abstract] [Full Text] [Related]
32. Treatment of human immunodeficiencies. Parkman R Clin Immunol Rev; 1981-1982; 1(3):375-408. PubMed ID: 6819914 [No Abstract] [Full Text] [Related]
33. Thymic hormone deficiency in normal ageing and Down's syndrome: is there a primary failure of the thymus? Fabris N; Mocchegiani E; Amadio L; Zannotti M; Licastro F; Franceschi C Lancet; 1984 May; 1(8384):983-6. PubMed ID: 6143966 [TBL] [Abstract][Full Text] [Related]
34. Transplantation of bone-marrow cells and fetal thymus in an infant with lymphopenic immunological deficiency. De Koning J; Van Bekkum DW; Dicke KA; Dooren LJ; Rádl J; Van Rood JJ Lancet; 1969 Jun; 1(7608):1223-7. PubMed ID: 4182410 [No Abstract] [Full Text] [Related]
35. [Therapeutic prospects in some immune deficiency syndromes and other pathological conditions connected with immune disorders]. Kraj M; Cieśluk S Acta Haematol Pol; 1976 OCT-DEC; 7(4):327-35. PubMed ID: 793282 [No Abstract] [Full Text] [Related]
36. Transplantation of lymphoid cells in patients with severe combined immunodeficiency (SCID). Griscelli C; Durandy A; Virelizier JL; Buriot D Haematol Blood Transfus; 1980; 25():403-9. PubMed ID: 7021358 [TBL] [Abstract][Full Text] [Related]
37. Effect of synthetic thymic hormone (TP5) in children with T-cell immunodeficiencies. Levinsky RJ; Davies EG; Goldstein G Birth Defects Orig Artic Ser; 1983; 19(3):273-6. PubMed ID: 6360239 [No Abstract] [Full Text] [Related]
38. Thymic humoral factor (THF) therapy in a patient with Di-George syndrome. Ersoy F; Sanal O; Yeğin O; Berkel AI; Cağlar M Turk J Pediatr; 1982; 23(2):115-20. PubMed ID: 7201177 [No Abstract] [Full Text] [Related]
39. T- and B-cell chimerism in two patients with severe combined immunodeficiency (SCID) after transplantation. Griscelli C; Durandy A; Ballet JJ; Prieur AM; Hors J Transplant Proc; 1977 Mar; 9(1):171-5. PubMed ID: 325757 [No Abstract] [Full Text] [Related]
40. Use of thymic grafts or thymic factors to augment immunologic recovery after bone marrow transplantation: brief report with 2 to 12 years' follow-up. Witherspoon RP; Sullivan KM; Lum LG; Goehle S; Atkinson MK; Ochs HD; Doney KC; Hansen JA; Sanders JE; Storb R Bone Marrow Transplant; 1988 Sep; 3(5):425-35. PubMed ID: 3056551 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]